SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16967I have believed for some time now that anti-cd40 will most likely be the first cRobert K.-7/1/2004
16966Bob, it had subpart E designation. Why didn't the FDA follow their own guidBluegreen-7/1/2004
16965Bob, why don't they resubmit? From that last article I posted.>>>&Bluegreen-7/1/2004
16964George, what do you think the chances of this being approved if an HIV drug?>Bluegreen-7/1/2004
16963Bob, scroll down to the oncology part to see anti-cd40. What is the deal?>&gBluegreen-7/1/2004
16962Bob, Chiron has listed anti-cd40, since it is cancer related is Xoma part of it?Bluegreen-7/1/2004
16961Bob, what have you come up with in regard to anti-cd40? Did DNA drop their antiBluegreen-7/1/2004
16960Lets just say the therapeutic potential of Raptiva just expanded a bit. How manyRobert K.-7/1/2004
16959So, what would happen if you added an anti-tnf???>>>>>http://bme.Bluegreen-6/30/2004
16958Bob, have you seen this?>>>>http://www.tau.ac.il/medicine/conf2002/FBluegreen-6/30/2004
16957Bob, look at the focus of this little get together. If you go, make sure you geBluegreen-6/30/2004
16956this one....has particularly broad indications. Think prednisone.....(albiet a lRobert K.-6/29/2004
16955Bob, what are the odds that Raptiva will only work for Psoriasis? What are the Bluegreen-6/29/2004
16954No. It looks like you are well on the case. I am lettin you do the legwork for nRobert K.-6/29/2004
16953Bob, have you found out anything about Cytolin?Bluegreen-6/29/2004
16952George, check out the poster presentations that start on page 12. Looks like RaBluegreen-6/29/2004
16951you know I have been talking combo. Buy my focus has been with anti-tnf. AnotherRobert K.-6/27/2004
16950Bob, so what has your research shown as possible combination therapies?>>&Bluegreen-6/27/2004
16949the daily chart is starting to look healthy. bottom in? maybe good risk/rewardtom r. phillips-6/26/2004
16948Bob, is looking at MS like Neuprex looking at Crohn's? I can't wait forBluegreen-6/26/2004
16947Found this on the net as a comment on Raptiva. Means absolutely NOTHING, but I fRobert K.-6/25/2004
16946Blue > Dr hildreth was the topic last year. You are currently 1 year behind mRobert K.-6/25/2004
16945Blue > real interesting topics that you like to rave about. Enjoy. (make sureRobert K.-6/25/2004
16944Bob, look at the last paragraph regarding Raptiva. Hey, do you think one of GenBluegreen-6/23/2004
16943George, read and reread the quotes from this dermatologist. Have you EVER seen Bluegreen-6/23/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News